Black Diamond Therapeutics (BDTX) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.54
-0.47
-0.41
-0.34

Details

Expected EPS
-0.43425
Actual EPS
-0.35
Surprise EPS
0.08
Surprise Percent
+19.4%

Description

Black Diamond Therapeutics (BDTX) has reported earnings of -0.35 per share for Q2 2024.

0 Comments

Share your thoughts